Local Boston Dalmatian Named Eukanuba Challenge Champion Finalist

Friday, May 20, 2011 General News J E 4

MASON, Ohio, May 20, 2011 /PRNewswire/ --

WHO:  Dalmatian – Alex – from Beverly, MA was just named a finalist in the Eukanuba 28-Day Challenge Champion Contest; there will be a total of five finalists. As a finalist, Alex and four other canines from around the U.S. have each won a year's supply of Eukanuba food.


WHAT:  Between Feb. 15 and April 30, 2011, dog owners taking the 28-Day Challenge were encouraged to enter the Challenge Champion Contest by submitting 100 words or less to explain their dog's transformation from good to extraordinary while eating Eukanuba for just 28 days. The winning "Challenge Champion" will be announced on Eukanuba's Facebook page Monday, June 6, 2011. The top dog will receive the pink carpet treatment with a Hollywood-style photo and video shoot, appear in the September issue of Dog Fancy magazine and star in an upcoming Eukanuba print advertisement.

ABOUT ALEX:  Alex, the 8-month old Dalmatian, completed the 28-Day Challenge and saw astounding results. After making the switch, he ran further, jumped higher and couldn't wait until meal time. He is an active, young show dog that physically flourished on Eukanuba and is well on his way to being a top dog in the show world. In fact, on the 28th day of the Challenge, Alex received a five point major reserve during his first weekend competing in show.


  • Interview Alex's owner to hear her reaction to being named a finalist and learn first-hand about Alex's show background and transformation since switching to Eukanuba
  • Videos and images of Alex and her owner
  • Interview Eukanuba spokesperson to learn why Alex stood out to be named a finalist

SOURCE Eukanuba



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Gen-Probe Files for US Regulatory Clearance of PAN...
Amgen Receives CHMP Positive Opinion for XGEVA™ (D...